Paeoniflorin exerts neuroprotective effects in a transgenic mouse model of Alzheimer’s disease via activation of adenosine A1 receptor
- 1 May 2020
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 730, 135016
- https://doi.org/10.1016/j.neulet.2020.135016
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of China (81673689)
This publication has 33 references indexed in Scilit:
- Coadministration of cannabinoid CB1-receptor and adenosine A1-receptor antagonists improves the acquisition of spatial memory in miceBehavioural Pharmacology, 2012
- Morris Water Maze Test for Learning and Memory Deficits in Alzheimer's Disease Model MiceJournal of Visualized Experiments, 2011
- Alzheimer's DiseaseNew England Journal of Medicine, 2010
- Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque FormationJournal of Neuroscience, 2006
- Kinetic distribution of paeoniflorin in cortex of normal and cerebral ischemia-reperfusion rats after intravenous administration ofPaeoniae Radix extractBiomedical Chromatography, 2006
- Morris water maze: procedures for assessing spatial and related forms of learning and memoryNature Protocols, 2006
- Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptorBritish Journal of Pharmacology, 2006
- Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonistsBritish Journal of Pharmacology, 2005
- A1 Adenosine Receptor Upregulation and Activation Attenuates Neuroinflammation and Demyelination in a Model of Multiple SclerosisJournal of Neuroscience, 2004
- 1,3-Dipropyl-8-cyclopentyl xanthine (DPCPX): A Useful Tool for Pharmacologists and Physiologists?General Pharmacology: The Vascular System, 1994